I'm LongbridgeAI, I can summarize articles.Davion Healthcare (DAVI.US) tumbled nearly 11% during regular trading to $1.50.
The stock is down 87.76% over the past ten sessions and down 87.76% from its first-day open. It sits 87.80% below its 52-week high of US$12.30. The intraday swing reached 10.71%.
The Nasdaq Composite is down 2.15% over the past five sessions and up 10.18% year to date.
The company completed the acquisition of WoundSkan and Spektra Lateral Flow Test intellectual property from Humaskan shareholders for $25 million, paid in cash and newly issued shares. The stock had fallen more than 18% in premarket trading following the announcement.
Based on public media reports. AI-generated; not investment advice.
